Skip to content
OpenCapital
Get started

Ultragenyx Pharmaceutical RARE Deferred compensation obligation

Deferred compensation obligation at other companies

Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$10M+32.2%
Erie Indemnity Company logo
Erie Indemnity CompanyERIE
$25.07M+6.9%
Preformed Line Products logo
Preformed Line ProductsPLPC
$9.59M-0.1%
CHE
ChemedCHE
$2.4M+6.0%
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$26M0.0%
HEICO logo
HEICOHEI
$8.1M+11.3%

Other financials

Income statement

See full
Revenue$136.0M-2.2%
Operating income-$169.0M-18.2%
Net income-$185.0M-22.5%
EPS (diluted)-$1.84-17.2%

Balance sheet

See full
Cash & equivalents$175.0M+37.8%
Total debt$36.0M-10.8%
Total equity-$236.0M-264%
Total assets$1.3B-1.2%

Cash flow

See full
Operating cash flow-$197.0M-18.7%
CapEx$1.0M0.0%
Free cash flow-$198.0M-18.6%

Valuation

See full
Market cap$2.83B-39.4%
P/S4.2×-3.7×

Profitability

See full
Gross margin97.2%—
Operating margin-83.8%-3.0pp
Net margin-90.9%-2.1pp
FCF margin-75.1%+10.7pp

Returns & leverage

See full
Return on equity-325.6%+36.9pp
Debt / equity3.7×—
Current ratio2×-0.4×

Where this comes from

Reported directly by Ultragenyx Pharmaceutical in its filing.

Tagged under the XBRL concept us-gaap:TreasuryStockDeferredEmployeeStockOwnershipPlan.

The official record: Ultragenyx Pharmaceutical’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ultragenyx Pharmaceutical's deferred compensation obligation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ultragenyx Pharmaceutical's deferred compensation obligation?
Ultragenyx Pharmaceutical (RARE) reported deferred compensation obligation of $10M in Q1 2026.
How has Ultragenyx Pharmaceutical's deferred compensation obligation changed year-over-year?
Ultragenyx Pharmaceutical's deferred compensation obligation increased by 32.2% year-over-year, from $7.57M to $10M.
What does deferred compensation obligation mean?
This represents the liability associated with deferred compensation arrangements, typically involving stock-based incentives or employee benefit plans that have been earned but not yet settled. It reflects the company's future obligation to deliver equity or cash to employees as part of long-term compensation structures. Tracking this metric helps investors evaluate the potential dilution or cash outflow associated with employee retention and incentive programs.